Top Markets
#1 MowCat MowCat +48.90%
#2 Derive Derive +29.23%
#3 Geodnet Geodnet +19.87%
#4 Audiera Audiera +16.20%
#5 Cross Cross +15.78%
#6 aPriori aPriori +14.46%
#7 Humanity Humanity +11.58%
#8 Biconomy Biconomy +10.06%
#9 Quack AI Quack AI +10.02%
#10 Cap Cap +9.80%
Coin of the day
MowCat MowCat
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Telo Genomics Corp. Telo Genomics Corp.

Telo Genomics Corp.

TELO
Classifica tra le azioni #35884
Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on... Telo Genomics Corp. (TELO.V) operates as a biotechnology firm focused on creating and bringing to market advanced predictive solutions. Its core mission is to enable personalized treatment approaches for individuals suffering from specific health conditions. The company's primary innovation is a sophisticated telomere analysis platform, which serves both to diagnose diseases and to forecast patient outcomes. This technology, often integrated with liquid biopsies, provides crucial insights for applications in both cancer and neurological illnesses. Their leading product, Telo-MM, is specifically designed to arm medical professionals with vital, actionable information for effectively managing Multiple Myeloma, a serious blood cancer. Additionally, Telo Genomics offers TeloView, a proprietary software system capable of precisely measuring individual patient telomere characteristics. Telo Genomics caters to a broad spectrum of clients, including diagnostic pathologists, clinical doctors, academic researchers, and pharmaceutical developers. A notable endorsement of its technology is a collaborative agreement with the renowned Mayo Clinic, aimed at validating the Telo-MM diagnostic tests for multiple myeloma. Founded in 2014 and based in Toronto, Canada, the company adopted its current name, Telo Genomics Corp., in April 2019, having previously operated as 3D Signatures Inc.
Prezzo delle azioni
$0.03302716
Ultima sincronizzazione: 2026-08-13
Capitalizzazione di mercato
$3.32M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-34.80%
Paese
CA
Scambia Telo Genomics Corp. (TELO)

Categoria

Healthcare
Rapporto P/S per Telo Genomics Corp. (TELO)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Telo Genomics Corp., il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Telo Genomics Corp. da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
4.72 -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
5.67 -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
- -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
16.40 -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
9.55 -
US